Guggenheim Capital LLC Argenx Se Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Argenx Se stock. As of the latest transaction made, Guggenheim Capital LLC holds 4,007 shares of ARGX stock, worth $2.26 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,007

Previous 5,131 21.91%

Holding current value

$2.26 Million

Previous $2.21 Million 1.5%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$434.22 - $551.9 $488,063 - $620,335	-1,124 Reduced 21.91%	4,007 $2.17 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $373,098 - $473,224	-1,048 Reduced 16.96%	5,131 $2.21 Million
Q1 2024 May 14, 2024	BUY	$356.95 - $413.29 $541,493 - $626,960	1,517 Added 32.54%	6,179 $2.43 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $149,798 - $223,656	442 Added 10.47%	4,662 $1.77 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $284,768 - $422,839	-771 Reduced 15.45%	4,220 $2.07 Million
Q2 2023 Aug 11, 2023	SELL	$360.14 - $422.58 $1.29 Million - $1.51 Million	-3,578 Reduced 41.76%	4,991 $1.95 Million
Q1 2023 May 10, 2023	BUY	$334.23 - $403.65 $1.83 Million - $2.21 Million	5,485 Added 177.85%	8,569 $3.19 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $994,688 - $1.17 Million	-2,907 Reduced 48.52%	3,084 $1.17 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $31,574 - $36,409	-92 Reduced 1.51%	5,991 $2.12 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $630,817 - $886,579	2,340 Added 62.52%	6,083 $2.31 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $93,383 - $128,839	367 Added 10.87%	3,743 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $22,032 - $28,595	-81 Reduced 2.34%	3,376 $1.18 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $23,600 - $28,046	-80 Reduced 2.26%	3,457 $1.04 Million
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $41,651 - $51,827	162 Added 4.8%	3,537 $1.07 Million
Q1 2021 May 13, 2021	BUY	$268.3 - $380.31 $431,694 - $611,918	1,609 Added 91.11%	3,375 $929,000
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $438,197 - $544,563	1,766 New	1,766 $519,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Argenx Se Transaction History